AI Terminal
RIT Capital Partners PLC
Board/Management Information • Sep 28, 2023
4696_rns_2023-09-28_35ca878a-dd1d-4c98-9a59-f15586d30074.html
Board/Management Information
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 0495O
RIT Capital Partners PLC
28 September 2023
RIT CAPITAL PARTNERS PLC (LEI: P31Q1NLTW35JJGHA4667)
28 September 2023
Directorate Change
RIT Capital Partners plc ('RIT' or the 'Company') announces today that Maxim Parr has retired as a non-executive director of RIT.
Following his retirement, Mr. Parr will take on the position of Chair at J. Rothschild Capital Management Limited, thereby bringing additional resources and further enhancing the expertise of the senior leadership team.
Sir James Leigh-Pemberton, Chairman, commented:
"On behalf of the RIT Board, I would like to thank Maxim for his exemplary service to the Company. He has made a distinguished contribution and my colleagues and I look forward to working with him in his new role."
With effect from Mr. Parr's retirement, Cecilia McAnulty, an independent non-executive director, has been appointed Chair of the Valuation Committee.
For more information:
J. Rothschild Capital Management (Investment Manager):
T: 020 7647 8565
Numis (Joint Broker):
David Benda
T: 020 7260 1000
JP Morgan Cazenove (Joint Broker):
William Simmonds
T: 020 3493 8000
Brunswick Group LLP (Media enquiries):
Nick Cosgrove, Tom Burns
T: 020 7404 5959E: [email protected]
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
BOAZVLFLXKLXBBB